StockDuty ← Dashboard Nov 05, 2026 04:10 AM ET
SignalFixed Income

PacBio narrows 2026 revenue guidance to $155M-$160M while targeting cash flow breakeven in 2028

PacBio narrowed 2026 revenue guidance to $155M-$160M and targets 2028 cash flow breakeven.

What changed
PacBio narrowed 2026 revenue guidance to $155M-$160M and targets 2028 cash flow breakeven.
Why it matters
PacBio narrowed 2026 revenue guidance to $155M-$160M and targets 2028 cash flow breakeven. — impact context not separately stored; see What changed.
Sources
seekingalpha
Related signals
US TREASURY YIELDS CONTINUE TO BREAK HIGHER — IS 6% NOW IN PLAY? →10 - YEAR TREASURY YIELD HITS 5.1 % FOR FIRST TIME IN 19 YEARS →EMERGENCY DOCTOR'S TIPS TO SURVIVE EXTREME HEAT THAT WILL BROIL ENTIRE CITIES - CBS →